Requip CR tablets 8mg, manufactured by GlaxoSmithKline, contain Ropinirole Hydrochloride. This controlled-release medication, with YJ code 1169013G2029 and a standard of 8mg per tablet, is used to treat Parkinson’s disease.
Requip CR tablets 8mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
